Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZRANB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ZSCAN12 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
mRNA | ZSCAN30 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | ZSCAN5A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZYG11B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | ZZEF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |